SCHEMBL28690482

SCHEMBL28690482

CC(C)(C)OC(=O)NCCc1ccc(C2CN(c3ccc(CCNC(=O)OC(C)(C)C)cc3)CCN2C(=O)OCc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.51
TMEM97 Q5BJF2 7/20 0.51
NR1H2 P55055 4/20 0.47
NR1H3 Q13133 4/20 0.47
NAMPT P43490 1/20 0.45
NAPEPLD Q6IQ20 1/20 0.44
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
TSHR P16473 1/20 0.42
RAB9A P51151 1/20 0.42
PDK1 Q15118 1/20 0.42
PDK2 Q15119 1/20 0.42
PDK3 Q15120 1/20 0.42
PDK4 Q16654 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28931799 0.93 NR1H2 (0.51) SIGMAR1TMEM97NR1H2NR1H3NAMPT
SCHEMBL28672619 0.85 PDE4B (0.46) SIGMAR1TMEM97NR1H2NR1H3CYP3A4
SCHEMBL28681451 0.84 SIGMAR1 (0.46) SIGMAR1TMEM97
SCHEMBL19211125 0.84 SIGMAR1 (0.52) SIGMAR1TMEM97NAMPTMAPT
SCHEMBL28690516 0.79 NR1H2 (0.48) NR1H2NR1H3MAPT
SCHEMBL2707267 0.79 SIGMAR1 (0.61) SIGMAR1TMEM97NR1H2NR1H3NAPEPLD
SCHEMBL19211083 0.78 SMN1; SMN2 (0.52) SIGMAR1NAMPTMAPT
SCHEMBL28681437 0.77 ABCB1 (0.46) NR1H2NR1H3NAMPTCYP3A4MAPT
SCHEMBL28683481 0.76 PDK1 (0.39) SIGMAR1TMEM97NAPEPLDCYP3A4MAPT
SCHEMBL28679751 0.76 NR1H2 (0.52) NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071560-B Thienopyridine carboxamides as ubiquitin-specific protease inhibitors 瓦洛健康公司 2022-01-14 CN disclosed
CN-109071561-B Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors 福马治疗股份有限公司 2022-01-14 CN disclosed